• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由源自头孢菌素酶-33(ADC-33)的另一种水解机制赋予的对氧亚氨基头孢菌素的耐药性,ADC-33是一种存在于耐碳青霉烯类肠杆菌科细菌(CR)中的C类β-内酰胺酶。

Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the -derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant (CR).

作者信息

Powers Rachel A, Wallar Bradley J, Jarvis Hannah R, Ziegler Zoe X, June Cynthia M, Bethel Christopher R, Hujer Andrea M, Taracila Magdalena A, Rudin Susan D, Hujer Kristine M, Prati Fabio, Caselli Emilia, Bonomo Robert A

机构信息

Department of Chemistry, Grand Valley State University, Allendale, Michigan, USA.

Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.

出版信息

mBio. 2025 Jun 11;16(6):e0028725. doi: 10.1128/mbio.00287-25. Epub 2025 May 16.

DOI:10.1128/mbio.00287-25
PMID:40377322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12153338/
Abstract

Antimicrobial resistance in is partly mediated by chromosomal class C β-lactamases, the -derived cephalosporinases (ADCs). Recently, a growing number of emerging variants were described, expanding this threat. Consistent with other β-lactamases, one of the main areas of variance exists in the Ω-loop region near the site of cephalosporin binding. Interestingly, a common alanine duplication (Adup) is found in this region. Herein, we studied specific Adup variants expressed in a uniform genetic background that demonstrated high-level resistance to multiple oxyimino-cephalosporins. For ceftolozane and ceftazidime, the Adup ADCs significantly increased levels of resistance (minimum inhibitory concentration [MIC] ≥ 512 µg/mL and MIC ≥ 1,024 µg/mL, respectively). These observations were consistent with the increased / for ceftazidime. For cefiderocol, three Adup variants exhibited increased MICs and increased / for this compound. Timed electrospray ionization mass spectrometry demonstrated stable cephalosporin:ADC adducts with ADC-30 (non-Adup), but not with ADC-33 (Adup), consistent with turnover. The X-ray crystal structure of Adup variant ADC-33 in complex with ceftazidime was determined (1.57 Å resolution) and suggests that increased turnover is facilitated by conformational changes (shift in Tyr221 and orientation of the oxyimino portion of the R1 side chain) and repositioning of water in the active site. These changes appear to favor substrate-assisted catalysis as an alternative mechanism to base-assisted catalysis. These studies also provide unprecedented insight into the mechanism underlying oxyimino-cephalosporin hydrolysis by expanded-spectrum ADC β-lactamases and possibly other class C β-lactamases, which is of critical importance to future drug design.IMPORTANCEThe characterization of emerging -derived cephalosporinase (ADC) variants is necessary to understand the increasing resistance to β-lactam antibiotics in spp. In this study, cefiderocol retains effectiveness against ADC variants with and without an Ω-loop alanine duplication (Adup). However, the presence of the Adup appears to introduce loop flexibility and structural alterations resulting in increased resistance and steady-state turnover of larger cephalosporins. Further characterization provides unprecedented insight into the mechanism of cephalosporin hydrolysis by ADC β-lactamases and supports a concomitant increase in ADC structural flexibility and cephalosporin affinity that leads to more efficient hydrolysis. In addition, the crystal structure of ADC-33 in complex with ceftazidime is consistent with a substrate-assisted catalysis mechanism. The structural differences in the ADC-33 active site leading to ceftazidime catalysis provide a better understanding of β-lactamase Adup variants and open important opportunities for future drug design and development.

摘要

中的抗菌药物耐药性部分由染色体C类β-内酰胺酶介导,即源自的头孢菌素酶(ADCs)。最近,越来越多的新兴变体被描述出来,扩大了这种威胁。与其他β-内酰胺酶一致,主要的变异区域之一存在于头孢菌素结合位点附近的Ω环区域。有趣的是,在该区域发现了常见的丙氨酸重复(Adup)。在此,我们研究了在统一的遗传背景中表达的特定Adup变体,这些变体对多种氧亚氨基头孢菌素表现出高水平耐药性。对于头孢洛扎/他唑巴坦和头孢他啶,Adup ADCs显著提高了耐药水平(最低抑菌浓度[MIC]分别≥512 μg/mL和MIC≥1024 μg/mL)。这些观察结果与头孢他啶的/增加一致。对于头孢地尔,三种Adup变体对该化合物的MIC增加且/增加。定时电喷雾电离质谱显示头孢菌素:ADC加合物与ADC - 30(非Adup)稳定,但与ADC - 33(Adup)不稳定,这与周转情况一致。确定了Adup变体ADC - 33与头孢他啶复合物的X射线晶体结构(分辨率为1.57 Å),表明周转增加是由构象变化(Tyr221的移位和R1侧链氧亚氨基部分的取向)以及活性位点中水的重新定位所促进的。这些变化似乎有利于底物辅助催化作为碱辅助催化的替代机制。这些研究还为广谱ADCβ-内酰胺酶以及可能其他C类β-内酰胺酶水解氧亚氨基头孢菌素的机制提供了前所未有的见解,这对未来药物设计至关重要。重要性对新兴的源自的头孢菌素酶(ADC)变体进行表征对于理解 spp. 中对β-内酰胺抗生素耐药性增加的情况是必要的。在本研究中,头孢地尔对有和没有Ω环丙氨酸重复(Adup)的ADC变体均保持有效性。然而,Adup的存在似乎引入了环的灵活性和结构改变,导致对更大头孢菌素的耐药性增加和稳态周转。进一步的表征为ADCβ-内酰胺酶水解头孢菌素的机制提供了前所未有的见解,并支持ADC结构灵活性和头孢菌素亲和力的同时增加,从而导致更有效的水解。此外,ADC - 33与头孢他啶复合物的晶体结构与底物辅助催化机制一致。导致头孢他啶催化的ADC - 33活性位点的结构差异有助于更好地理解β-内酰胺酶Adup变体,并为未来药物设计和开发提供重要机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c99710583a89/mbio.00287-25.f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/b495ab552dec/mbio.00287-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c947bd570185/mbio.00287-25.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/88028f7cca2e/mbio.00287-25.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c5f95d87a309/mbio.00287-25.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/18570e36d7d8/mbio.00287-25.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/d869c95ad137/mbio.00287-25.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/54c1566716ec/mbio.00287-25.f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/4e4aca7ebf87/mbio.00287-25.f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c99710583a89/mbio.00287-25.f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/b495ab552dec/mbio.00287-25.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c947bd570185/mbio.00287-25.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/88028f7cca2e/mbio.00287-25.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c5f95d87a309/mbio.00287-25.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/18570e36d7d8/mbio.00287-25.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/d869c95ad137/mbio.00287-25.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/54c1566716ec/mbio.00287-25.f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/4e4aca7ebf87/mbio.00287-25.f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b824/12153338/c99710583a89/mbio.00287-25.f009.jpg

相似文献

1
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the -derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant (CR).由源自头孢菌素酶-33(ADC-33)的另一种水解机制赋予的对氧亚氨基头孢菌素的耐药性,ADC-33是一种存在于耐碳青霉烯类肠杆菌科细菌(CR)中的C类β-内酰胺酶。
mBio. 2025 Jun 11;16(6):e0028725. doi: 10.1128/mbio.00287-25. Epub 2025 May 16.
2
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes.鲍曼不动杆菌头孢菌素酶ADC-7β-内酰胺酶新等位基因变体的鉴定:定义一个独特的C类酶家族。
Antimicrob Agents Chemother. 2005 Jul;49(7):2941-8. doi: 10.1128/AAC.49.7.2941-2948.2005.
3
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits -Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum.新型硼酸过渡态抑制剂 MB076 的合成:杂环三唑有效抑制具有扩展底物谱的 - 衍生头孢菌素酶变体。
J Med Chem. 2023 Jul 13;66(13):8510-8525. doi: 10.1021/acs.jmedchem.3c00144. Epub 2023 Jun 26.
4
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.抑制不动杆菌属的 C 类β-内酰胺酶:有效抑制剂设计的见解。
Biochemistry. 2010 Jan 19;49(2):329-40. doi: 10.1021/bi9015988.
5
Extended-spectrum cephalosporinase in Acinetobacter baumannii.鲍曼不动杆菌中的超广谱头孢菌素酶。
Antimicrob Agents Chemother. 2010 Aug;54(8):3484-8. doi: 10.1128/AAC.00050-10. Epub 2010 Jun 14.
6
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.解析铜绿假单胞菌头孢他啶-他唑巴坦耐药性的演变。
mBio. 2018 Dec 11;9(6):e02085-18. doi: 10.1128/mBio.02085-18.
7
Evolution of carbapenemase activity in the class C β-lactamase ADC-1.C类β-内酰胺酶ADC-1中碳青霉烯酶活性的演变
mBio. 2025 Jun 11;16(6):e0018525. doi: 10.1128/mbio.00185-25. Epub 2025 Apr 28.
8
Extended-spectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime.鲍曼不动杆菌中扩展谱型 AmpC 头孢菌素酶:ADC-56 导致对头孢吡肟的耐药性。
Antimicrob Agents Chemother. 2011 Oct;55(10):4922-5. doi: 10.1128/AAC.00704-11. Epub 2011 Jul 25.
9
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.ADC-68的结构,一种从鲍曼不动杆菌中分离出的新型碳青霉烯水解C类超广谱β-内酰胺酶。
Acta Crystallogr D Biol Crystallogr. 2014 Nov;70(Pt 11):2924-36. doi: 10.1107/S1399004714019543. Epub 2014 Oct 23.
10
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.针对鲍曼不动杆菌ADC-7头孢菌素酶的抑制剂的生化与结构分析
Biochemistry. 2014 Dec 9;53(48):7670-9. doi: 10.1021/bi500887n. Epub 2014 Nov 25.

本文引用的文献

1
β-Lactamase diversity in .β-内酰胺酶在……中的多样性
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0078524. doi: 10.1128/aac.00785-24. Epub 2025 Feb 10.
2
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate.D179Y 变异型 KPC 碳青霉烯酶水解头孢他啶和头孢地尔的机制相似,涉及形成长寿命的共价中间物。
Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0110823. doi: 10.1128/aac.01108-23. Epub 2024 Jan 23.
3
The Structural Role of N170 in Substrate-Assisted Deacylation in KPC-2 β-Lactamase.
N170 在 KPC-2 β-内酰胺酶的基质辅助脱酰基反应中的结构作用。
Angew Chem Int Ed Engl. 2024 Mar 18;63(12):e202317315. doi: 10.1002/anie.202317315. Epub 2024 Feb 12.
4
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in -derived cephalosporinase.天然蛋白质工程中的 Ω 环:Y221 在源于头孢菌素酶的头孢他啶和头孢洛扎烷耐药性中的作用。
Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0079123. doi: 10.1128/aac.00791-23. Epub 2023 Oct 18.
5
An NDM-Producing Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance.一株产NDM的临床分离株对头孢地尔、头孢他啶-阿维巴坦合剂及氨曲南耐药:迈向泛β-内酰胺耐药的又一步。
Open Forum Infect Dis. 2023 May 17;10(7):ofad276. doi: 10.1093/ofid/ofad276. eCollection 2023 Jul.
6
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits -Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum.新型硼酸过渡态抑制剂 MB076 的合成:杂环三唑有效抑制具有扩展底物谱的 - 衍生头孢菌素酶变体。
J Med Chem. 2023 Jul 13;66(13):8510-8525. doi: 10.1021/acs.jmedchem.3c00144. Epub 2023 Jun 26.
7
Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.铁转运系统和β-内酰胺酶对纽约市地方性鲍曼不动杆菌临床分离株对头孢地尔耐药的贡献。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0023423. doi: 10.1128/aac.00234-23. Epub 2023 May 22.
8
Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor.快速筛选出一株产NDM-5的耐头孢地尔大肠杆菌,该菌与铁载体受体CirA中的单个氨基酸取代有关。
J Antimicrob Chemother. 2023 Apr 3;78(4):1125-1127. doi: 10.1093/jac/dkad004.
9
Nosocomial outbreak by NDM-1-producing highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022.2021 年 8 月至 2022 年 6 月,意大利佛罗伦萨发生产 NDM-1 的耐碳青霉烯头孢地尔 洛高度耐药的医院感染爆发。
Euro Surveill. 2022 Oct;27(43). doi: 10.2807/1560-7917.ES.2022.27.43.2200795.
10
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosa.功能和结构表征的 OXA-935,一种新型的 OXA-10 家族β-内酰胺酶从铜绿假单胞菌。
Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0098522. doi: 10.1128/aac.00985-22. Epub 2022 Sep 21.